Bioxyne Limited (BXN) Stock Statistics & Valuation Metrics

Bioxyne Limited has a market cap or net worth of AU$112.09M. The enterprise value is AU$111.82M.

Bioxyne Limited has 2,239,909,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioxyne Limited’s return on equity (ROE) is 0.42 and return on invested capital (ROIC) is 43.07%.

The current PE Ratio of Bioxyne Limited is 3.2. Bioxyne Limited’s PEG ratio is -0.13.

In the last 12 months, Bioxyne Limited had revenue of 30.42M and earned 4.90M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 2.02M and capital expenditures -2.09M, giving a free cash flow of -62.22K billion.

Bioxyne Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Bioxyne Limited upcoming earnings date is Aug 28, 2026, TBA (Confirmed).

Bioxyne Limited as a current ratio of 2.03, with Debt / Equity ratio of 36.82%

In the past 12 months, Bioxyne Limited has paid -840.05K in taxes.

Bioxyne Limited EV to EBITDA ratio is 15.35, with an EV/FCF ratio of 21.23.

Bioxyne Limited has AU$7.60M in cash and marketable securities with AU$7.43M in debt, giving a net cash position of AU$173.90K billion.

Gross margin is 33.38%, with operating margin of 18.28%, and net profit margin of 16.11%.

The average price target for Bioxyne Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―